Pune (Maharashtra) [India], August 17 (ANI): Serum Institute of India (SII) acquired a 50 pc stake of SCHOTT Kaisha to become SCHOTT's joint venture partner and secure pharma packaging supply, Serum Institute of India announced on Tuesday.
Pune (Maharashtra) [India], August 14 (ANI): Mixing two different vaccines of COVID-19 is a very risky decision and it is must be discouraged, said Cyrus Poonawalla, chairman of Serum Institute of India (SII) on Friday.
New Delhi [India], August 13 (ANI): Serum Institute of India's chairman and managing director Cyrus Poonawalla on Friday praised the Narendra Modi government for bringing reforms in the vaccine industry for getting permissions and licences on priority and said difficulties to get licenses an
New Delhi [India], August 6 (ANI): In order to ramp up COVID-19 vaccine supply in the country, Union Health Minister Mansukh Mandaviya on Friday met Serum Institute of India (SII) CEO Adar Poonawalla in the national capital and held a discussion over the supply of Covishield vaccine.
New Delhi [India], July 30 (ANI): The Confederation of Indian Industry (CII) has entered into an agreement with the Serum Institute of India (SII) to accelerate COVID-19 vaccination in partnership with industry, including healthcare providers.
Paris [France), July 19 (ANI): France on Monday included Covishield produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University in the list of approved vaccines for travel to the country.
Pune (Maharashtra) [India], July 2 (ANI): Union Minister Mansukh Mandaviya on Friday visited a vaccine manufacturing plant of the Serum Institute of India in Pune to review the production of vaccines.
Amsterdam [Netherlands], July 2 (ANI): The Netherlands became the latest European Union (EU) country to approve the Serum Institute of India (SII)-manufactured Covishield vaccine for travellers, days after India pushed for the approval of its COVID-19 vaccines in Europe.
Zurich [Switzerland], July 1 (ANI): A day after external affairs minister S Jaishankar said he has taken up with European Union to accept COVID-19 vaccines, such as Covishield and Covaxin, for Indian nationals travelling to Europe, Switzerland, Iceland and seven European Union countries on T
New Delhi [India], July 1 (ANI): An expert panel constituted by the government has recommended against granting permission to the Serum Institute of India (SII) to conduct phase two and three clinical trials of Covavax COVID-19 vaccine on children aged between 2-17 years, said sources on
New Delhi [India], June 30 (ANI): Serum Institute of India is confident of receiving approval from the European Medicines Agency (EMA) for its COVID-19 vaccine Covishield in a month, the company's CEO Adar Poonawalla informed on Wednesday.
New Delhi [India], June 29 (ANI): EU Ambassador to India Ugo Astuto has clarified that there is no ban in the European Union on Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University.